Zevra Therapeutics, Inc. (ZVRA) NASDAQ
10.49
+0.1(+0.96%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 495.59M |
| Enterprise Value | 496.39M |
| P/E Ratio | 7.11 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 5.9 |
| Price/Book Ratio | 3.83 |
| Enterprise/Revenue | 5.91 |
| Enterprise/EBITDA | 6.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.78 |
| Operating Margin | -0.59 |
Management Effectiveness
| Return On Assets | 0.29 |
| Return On Equity | 0.75 |
Income Statement
| Revenue | 106.47M |
| Revenue/Share | 1.92 |
| Gross Profit | 89.99M |
| EBITDA | 98.71M |
| Net Income | 83.23M |
| Diluted EPS | 1.35 |
Balance Sheet
| Total Cash | 191.01M |
| Total Cash/Share | 3.45 |
| Total Debt | 63.21M |
| Total Debt/Equity | 0.41 |
| Current Ratio | 5.68 |
| Book Value Per Share | 2.8 |
Price History
| 52-Week Change | 46.44 |
| 52-Week High | 13.16 |
| 52-Week Low | 7.01 |
| Moving Average 50 Days | 9.38 |
| Moving Average 200 Days | 9.54 |
Statistics
| Average Volume | 1.03M |
| Shares Outstanding | 58.71M |
| % Held by Institutions | 68.18 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | December 28, 2020 |
